<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jeffries CD</submitter><funding>NIDDK NIH HHS</funding><funding>NIMH NIH HHS</funding><pagination>e981</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5290334</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6(12)</volume><pubmed_abstract>Dysregulation of immune system functions has been implicated in schizophrenia, suggesting that immune cells may be involved in the development of the disorder. With the goal of a biomarker assay for psychosis risk, we performed small RNA sequencing on RNA isolated from circulating immune cells. We compared baseline microRNA (miRNA) expression for persons who were unaffected (n=27) or who, over a subsequent 2-year period, were at clinical high risk but did not progress to psychosis (n=37), or were at high risk and did progress to psychosis (n=30). A greedy algorithm process led to selection of five miRNAs that when summed with +1 weights distinguished progressed from nonprogressed subjects with an area under the receiver operating characteristic curve of 0.86. Of the five, miR-941 is human-</pubmed_abstract><journal>Translational psychiatry</journal><pubmed_title>Insights into psychosis risk from leukocyte microRNA expression.</pubmed_title><pmcid>PMC5290334</pmcid><funding_grant_id>U01 MH082022</funding_grant_id><funding_grant_id>U01 MH082004</funding_grant_id><funding_grant_id>U01 MH076989</funding_grant_id><funding_grant_id>U01 MH081928</funding_grant_id><funding_grant_id>P50 MH066286</funding_grant_id><funding_grant_id>P30 DK034987</funding_grant_id><funding_grant_id>R01 MH085521</funding_grant_id><funding_grant_id>R01 MH076989</funding_grant_id><funding_grant_id>U01 MH081984</funding_grant_id><funding_grant_id>U01 MH081902</funding_grant_id><funding_grant_id>U01 MH081857</funding_grant_id><funding_grant_id>U01 MH081988</funding_grant_id><funding_grant_id>U01 MH081944</funding_grant_id><pubmed_authors>Mathalon DH</pubmed_authors><pubmed_authors>Addington J</pubmed_authors><pubmed_authors>Bearden CE</pubmed_authors><pubmed_authors>Cadenhead KS</pubmed_authors><pubmed_authors>Cornblatt BA</pubmed_authors><pubmed_authors>Walker EF</pubmed_authors><pubmed_authors>Woods SW</pubmed_authors><pubmed_authors>Perkins DO</pubmed_authors><pubmed_authors>Jeffries CD</pubmed_authors><pubmed_authors>Glatt SJ</pubmed_authors><pubmed_authors>Stark T</pubmed_authors><pubmed_authors>McGlashan TH</pubmed_authors><pubmed_authors>Tsuang M</pubmed_authors><pubmed_authors>Seidman LJ</pubmed_authors><pubmed_authors>Chandler SD</pubmed_authors><pubmed_authors>Yeo E</pubmed_authors><pubmed_authors>Cannon TD</pubmed_authors></additional><is_claimable>false</is_claimable><name>Insights into psychosis risk from leukocyte microRNA expression.</name><description>Dysregulation of immune system functions has been implicated in schizophrenia, suggesting that immune cells may be involved in the development of the disorder. With the goal of a biomarker assay for psychosis risk, we performed small RNA sequencing on RNA isolated from circulating immune cells. We compared baseline microRNA (miRNA) expression for persons who were unaffected (n=27) or who, over a subsequent 2-year period, were at clinical high risk but did not progress to psychosis (n=37), or were at high risk and did progress to psychosis (n=30). A greedy algorithm process led to selection of five miRNAs that when summed with +1 weights distinguished progressed from nonprogressed subjects with an area under the receiver operating characteristic curve of 0.86. Of the five, miR-941 is human-</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Dec</publication><modification>2025-06-01T00:10:02.04Z</modification><creation>2025-06-01T00:10:02.04Z</creation></dates><accession>S-EPMC5290334</accession><cross_references><pubmed>27959328</pubmed><doi>10.1038/tp.2016.148</doi></cross_references></HashMap>